Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Muise, Eric S ^a   Souza, Sandra ^a   Chi, An ^a   Tan, Yejun ^a   Zhao, Xuemei ^a   Liu, Franklin ^a   Dallas yang, Qing ^a   Wu, Margaret ^a   Sarr, Tim ^a   Zhu, Lan ^a   Guo, Hongbo ^a   Li, Zhihua ^a   Li, Wenyu ^a   Hu, Weiwen ^a   Jiang, Guoqiang ^a   Paweletz, Cloud P ^a,b   Hendrickson, Ronald C ^a   Thompson, John R ^a   Mu, James ^a   Berger, Joel P ^a   Mehmet, Huseyin ^a   more..

^a MERCK RESEARCH LABORATORIES   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCOSE; INSULIN RECEPTOR; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; RNA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE EXPRESSION; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CLUSTER ANALYSIS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN; MALE; MICE; PHOSPHOPROTEINS; PROTEOME; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84883615750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073011     Document Type: Article

References (37)

1. Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, et al. (2010) Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 24: 2050-2064. doi:10.1210/me.2010-0142. PubMed: 20667984.
2. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, et al. (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115: 1627-1635. doi:10.1172/JCI23606. PubMed: 15902306.
3. Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, et al. (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148: 774-781. PubMed: 17068132.
4. Véniant MM, Komorowski R, Chen P, Stanislaus S, Winters K, et al. (2012) Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys. Endocrinology 153: 4192-4203. doi:10.1210/en.2012-1211. PubMed: 22798348.
5. Mu J, Pinkstaff J, Li Z, Skidmore L, Li N, et al. (2012) FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents. Diabetes 61: 505-512. doi:10.2337/db11-0838. PubMed: 22210323.
6. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, et al. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5: 426-437. doi:10.1016/j.cmet.2007.05.002. PubMed: 17550778.
7. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, et al. (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5: 415-425. doi:10.1016/j.cmet.2007.05.003. PubMed: 17550777.
8. Muise ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, et al. (2008) Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 74: 403-412. doi:10.1124/mol.108.044826. PubMed: 18467542.
9. Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, et al. (2012) Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell 148: 556-567. doi:10.1016/j.cell.2011.11.062. PubMed: 22304921.
10. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, et al. (2007) Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282: 26687-26695. doi:10.1074/jbc.M704165200. PubMed: 17623664.
11. Xu J, Stanislaus S, Chinookoswong N, Lau YY, Hager T, et al. (2009) Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects. Am J Physiol Endocrinol Metab 297: E1105-E1114. doi:10.1152/ajpendo.00348.2009. PubMed: 19706786.
12. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, et al. (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149: 6018-6027. doi:10.1210/en.2008-0816. PubMed: 18687777.
13. Moyers JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, et al. (2007) Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J Cell Physiol 210: 1-6. doi:10.1002/jcp.20847. PubMed: 17063460.
14. Ding X, Boney-Montoya J, Owen BM, Bookout AL, Coate KC, et al. (2012) betaKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism. Cell Metab 16: 387-393. doi:10.1016/j.cmet.2012.08.002. PubMed: 22958921.
15. Adams AC, Yang C, Coskun T, Cheng CC, Gimeno RE, et al. (2013) The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Molecular Metabolism 2: 31-37. doi:10.1016/j.molmet.2012.08.007.
16. Véniant MM, Hale C, Helmering J, Chen MM, Stanislaus S, et al. (2012) FGF21 promotes metabolic homeostasis via white adipose and leptin in mice. PLOS ONE 7: e40164. doi:10.1371/journal.pone.0040164. PubMed: 22792234.
17. Holland WL, Adams AC, Brozinick JT, Bui HH, Miyauchi Y, et al. (2013) An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17: 790-797. doi:10.1016/j.cmet.2013.03.019. PubMed: 23663742.
18. Lin Z, Tian H, Lam KS, Lin S, Hoo RC, et al. (2013) Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17: 779-789. doi:10.1016/j.cmet.2013.04.005. PubMed: 23663741.
19. Murphy M, Samms R, Warner A, Bolborea M, Barrett P, et al. (2012) Increased responses to the actions of fibroblast growth factor 21 on energy balance and body weight in a seasonal model of adiposity. J Neuroendocrinol.
20. Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, et al. (2012) FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26: 271-281. doi:10.1101/gad.177857.111. PubMed: 22302939.
21. Camacho RC, (2013) PEGylated FGF21 Rapidly Normalizes Insulin-Stimulated Glucose Utilization in Diet-Induced Insulin Resistant Mice. Eur J Pharmacol (. (2013)) PubMed: 23831019.
22. Zhao W, Fong O, Muise ES, Thompson JR, Weingarth D, et al. (2010) Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters. Mol Pharmacol 78: 350-359. doi:10.1124/mol.110.064980. PubMed: 20530130.
23. Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, et al. (1998) Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 273: 24665-24669. doi:10.1074/jbc.273.38.24665. PubMed: 9733764.
24. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386. doi:10.1074/mcp.M200025-MCP200. PubMed: 12118079.
25. Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, et al. (1996) Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol 10: 1457-1466. doi:10.1210/me.10.11.1457. PubMed: 8923470.
26. Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K, (1996) The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 271: 6497-6501. doi:10.1074/jbc.271.11.6497. PubMed: 8626452.
27. Minowada G, Miller YE, (2009) Overexpression of Sprouty 2 in mouse lung epithelium inhibits urethane-induced tumorigenesis. Am J Respir Cell Mol Biol 40: 31-37. doi:10.1165/rcmb.2008-0147OC. PubMed: 18635814.
28. Hunt MC, Rautanen A, Westin MA, Svensson LT, Alexson SE, (2006) Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J 20: 1855-1864. doi:10.1096/fj.06-6042com. PubMed: 16940157.
29. Maeda K, Uysal KT, Makowski L, Görgün CZ, Atsumi G, et al. (2003) Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52: 300-307. PubMed: 12540600.
30. Basantani MK, Sitnick MT, Cai L, Brenner DS, Gardner NP, et al. (2011) Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 52: 318-329. doi:10.1194/jlr.M011205. PubMed: 21068004.
31. Vidal-Puig AJ, Grujic D, Zhang CY, Hagen T, Boss O, et al. (2000) Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 275: 16258-16266. doi:10.1074/jbc.M910179199. PubMed: 10748196.
32. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, et al. (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143: 998-1007. doi:10.1210/en.143.3.998. PubMed: 11861525.
33. Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, et al. (2010) Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329: 454-457. doi:10.1126/science.1188280. PubMed: 20558665.
34. Hu W, Li L, Yang M, Luo X, Ran W, et al. (2013) Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J Clin Endocrinol Metab 98: 290-298. doi:10.1210/jc.2012-2466. PubMed: 23185036.
35. Ehrlund A, Mejhert N, Lorente-Cebrián S, Aström G, Dahlman I, et al. (2013) Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab 98: E503-E508. doi:10.1210/jc.2012-3416. PubMed: 23393180.
36. Wei W, Dutchak PA, Wang X, Ding X, Wang X, et al. (2012) Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma. Proc Natl Acad Sci U S A 109: 3143-3148. doi:10.1073/pnas.1200797109. PubMed: 22315431.
37. Wang H, Qiang L, Farmer SR, (2008) Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol 28: 188-200. doi:10.1128/MCB.00992-07. PubMed: 17954559.